Caplin Point Labs Gets USFDA Nod for Generic Eyedrop - Difluprednate
December 16, 2024 14:07
Caplin Point Labs receives USFDA approval for its generic version of Difluprednate eye drop, indicated for inflammation and pain after ocular surgery. The approval marks a significant milestone...